0000950123-14-006465.txt : 20140521 0000950123-14-006465.hdr.sgml : 20140521 20140520183359 ACCESSION NUMBER: 0000950123-14-006465 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140331 FILED AS OF DATE: 20140521 DATE AS OF CHANGE: 20140520 EFFECTIVENESS DATE: 20140521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abingworth LLP CENTRAL INDEX KEY: 0001397144 IRS NUMBER: 980518585 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14285 FILM NUMBER: 14859175 BUSINESS ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN BUSINESS PHONE: 44 (0)20 7534 1500 MAIL ADDRESS: STREET 1: 38 JERMYN STREET CITY: LONDON STATE: X0 ZIP: SW1Y 6DN 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001397144 XXXXXXXX 03-31-2014 03-31-2014 Abingworth LLP
38 Jermyn Street London X0 SW1Y 6DN
13F HOLDINGS REPORT 028-14285 Abingworth Management LTD N
John Heard General Counsel 44 2075341508 John Heard London X0 05-20-2014 1 13 181248 false 1 Abingworth Management LTD
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Amarin Spons ADR 023111206 14638 8087486 SH DFND 8087486 0 0 Anthera Common 03674U102 1467 437994 SH DFND 437994 0 0 Cempra Common 15130J109 8243 714285 SH DFND 714285 0 0 Dicerna Common 253031108 33314 1182196 SH DFND 1182196 0 0 GW Pharma (US) Spons ADR 36197T103 6067 102200 SH DFND 102200 0 0 Hyperion Common 44915N101 1612 62500 SH DFND 62500 0 0 Oncogenex Pharma Common 68230A106 7088 603740 SH DFND 603740 0 0 Portola Common 737010108 32140 1240912 SH DFND 1 1240912 0 0 Prosensa Common N71546100 34860 6213924 SH DFND 1 6213924 0 0 Regulus Common 75915K101 2943 327350 SH DFND 327350 0 0 Supernus Common 868459108 32148 3600000 SH DFND 1 3600000 0 0 Zalicus Common 98887C105 96 78966 SH DFND 78966 0 0 Zogenix Common 98978L105 6632 2335218 SH DFND 1 2335218 0 0